Iglesias Juan Fernando
Clinical trials sponsored by Iglesias Juan Fernando, explained in plain language.
-
New study aims to lower artery blockage risk in complex heart procedures
Disease control Recruiting nowThis study tests whether using a different spot on the wrist (distal radial artery) for a heart procedure can lower the chance of blocking the main wrist artery compared to the usual spot. About 708 adults needing complex heart treatment will be randomly assigned to one of two ac…
Phase: NA • Sponsor: IGLESIAS Juan Fernando • Aim: Disease control
Last updated Jun 17, 2026 05:59 UTC
-
New stent combo aims to cut bleeding risk in High-Risk heart patients
Disease control Recruiting nowThis study tests a new ultra-thin stent coated with a drug to keep arteries open, combined with a shorter course of two blood thinners (1-3 months) followed by just one blood thinner, in people with left main coronary artery disease. The goal is to see if this approach reduces ma…
Phase: NA • Sponsor: IGLESIAS Juan Fernando • Aim: Disease control
Last updated Jun 16, 2026 12:51 UTC
-
Heart attack patients may soon skip aspirin after stenting
Disease control Recruiting nowThis study looks at 350 heart attack patients who get a special stent and then take only a strong blood thinner (no aspirin) for a year. The goal is to see if this approach lowers bleeding risk as much as the standard aspirin-plus-blood-thinner combo, while still preventing futur…
Phase: NA • Sponsor: IGLESIAS Juan Fernando • Aim: Disease control
Last updated Jun 15, 2026 19:08 UTC